Beyond the Scale
The question for intermittent fasting is not only how many kilograms change. It is whether a fasting schedule adds a meaningful difference in body composition, metabolic health, daily well-being, safety, or sustainability beyond the short-term weight signal. The available evidence is much stronger for describing weight than for answering those wider questions, so this chapter separates the outcomes rather than allowing one favorable result to stand in for overall health benefit.
That separation matters in both directions. A diet can produce similar weight loss while differing in burden or quality of life. It can also produce a selective change in a marker without demonstrating better long-term health. The Málaga trial and the broader Cochrane review offer pieces of this picture, but they do not fill every gap.
Body composition is more informative than weight alone—but still limited
The randomized trial measured body fat mass and lean mass using bioelectrical impedance analysis. This method estimates body composition through electrical properties of the body and is common in clinical practice, but the authors acknowledge that it is less precise than dual-energy X-ray absorptiometry. That measurement choice does not make the results unusable. It does mean that small between-group differences should not be treated as exact measurements of tissue change.
All five interventions reduced body fat mass within their own groups over three months. The more relevant comparison is what happened relative to the calorie-restricted Mediterranean control. Early time-restricted eating and modified alternate-day fasting showed greater decreases in body fat mass. The late time-restricted group did not show a clear difference from control in body fat mass, and the ketogenic group’s confidence interval also included no clear between-group difference for that outcome. No intervention showed a difference from control in body lean mass.
This pattern is not a simple extension of the weight result. Late time-restricted eating showed a greater weight loss than control, but not a clear body-fat difference. Early time-restricted eating did not establish a weight advantage, yet it did show a greater decrease in body fat mass. Modified alternate-day fasting showed both a weight signal and a body-fat signal. These contrasts remind us that total weight, fat mass, and lean mass are related but not interchangeable outcomes.
They also illustrate why a null finding needs careful wording. The study did not establish a between-group difference in lean mass; it did not prove that the groups preserved lean tissue identically. The sample was divided among five arms, the intervention lasted only three months, and the measurement was less precise than a reference method. The result supports restraint, not a claim that no meaningful body-composition difference could exist.
The body-composition evidence therefore adds a qualified signal rather than a new general conclusion. Modified alternate-day fasting looks more interesting when the outcome is fat mass, and early time-restricted eating shows a pattern that is not captured by total weight alone. But the findings are arm-specific, short-term, and measured with a method whose limitations the authors state openly.